EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report)’s stock price was down 0.4% during mid-day trading on Tuesday . The stock traded as low as $13.04 and last traded at $13.44. 26,954 shares changed hands during trading, an increase of 147% from the average daily volume of 10,917 shares. The stock had previously closed at $13.49.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of EUDA Health in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, EUDA Health has a consensus rating of “Hold” and an average price target of $55.00.
Check Out Our Latest Analysis on EUDA Health
EUDA Health Stock Up 0.2%
Institutional Trading of EUDA Health
An institutional investor recently raised its stake in EUDA Health stock. Citadel Advisors LLC increased its position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA – Free Report) by 57.7% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 44,631 shares of the company’s stock after buying an additional 16,321 shares during the quarter. Citadel Advisors LLC owned about 0.12% of EUDA Health worth $78,000 as of its most recent SEC filing. 4.35% of the stock is currently owned by hedge funds and other institutional investors.
EUDA Health Company Profile
EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.
EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.
Read More
- Five stocks we like better than EUDA Health
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
